ANIP · Categories · Form 3

ANIP - SEC Form 3 initial insider statements

ANI Pharmaceuticals Inc. (ANIP) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.

Recent Form 3 for ANIP

• 791d
  New insider Rowland Thomas Andrew claimed ownership of 34,036 shares (SEC Form 3)

  3 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
• 1020d
  SEC Form 3 filed by new insider Leonard Matthew J

  3 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
• 1363d
  SEC Form 3 filed by new insider Davis Krista

  3 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
• 1419d
  SEC Form 3 filed by new insider Cook Meredith

  3 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
• 1539d
  SEC Form 3 filed by new insider Tannenbaum Renee P

  3 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
• 1658d
  SEC Form 3 filed by new insider Shanmugam Muthusamy

  3 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
• 1658d
  SEC Form 3 filed by new insider Gassert Chad

  3 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
• 1937d
  SEC Form 3 filed by Christopher Mutz

  3 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
• 1937d
  SEC Form 3 filed by Ori Gutwerg

  3 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)

Other ANIP categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends